Abstract
Purpose
To investigate risk factors of esotropia, anisometropia and amblyopia and compare the clinical features in hyper-metropic children according to the amount of hyperopia.
Methods
This study included 377 patients with cycloplegic refractive error of +1 D or greater at first visit. Patients were divided into 3 groups according to the refractive error. Odds ratios were calculated to evaluate the association of clinical risk factors with esotropia, anisometropi and amblyopia. Clinical features were compared between surgical and non-surgical groups.
Results
Hyperopia <+6 D showed greater odds of anisometropia. Hyperopia of ≥+6 D showed greater odds of bilateral am-blyopia to 14.796 and hyperopia of <+6 D increased odds of unilateral amblyopia. Moderate hyperopia (≥3 D to <6 D) increased the odds ratio for development of esotropia to 1.862. Patients with anisometropia ≥2 D had a 5.386 times increased odds of eso-tropia and those younger than 2 years had a 5.578 times increased odds of esotropia. Surgical groups showed lower amount of hyperopia than non-surgical groups. Hyperopia <+3 D had higher prevalence of esotropic surgery (50.72%).
Conclusions
Moderate hyperopia and anisometroia ≥2 D increased the risk for development of esotropia. Greater prevalence of bilateral amblyopia and lower prevalence of esotrpia was found predominantly in groups with higher amount of hyperopia. We recommend optical correction at an early age with higher hyperopia and surgical treatment should be considered for esotropic children with lower hyperopia.
References
1. Mutti DO, Mitchell GL, Jones LA. . Axial growth and changes in lenticular and corneal power during emmetropization in infants. Invest Ophthalmol Vis Sci. 2005; 46:3074–80.
2. Ingram RM, Arnold PE, Dally S, Lucas J. Results of a randomised trial of treating abnormal hypermetropia from the age of 6 months. Br J Ophthalmol. 1990; 74:158–9.
3. Giordano L, Friedman DS, Repka MX. . Prevalence of re-fractive error among preschool children in an urban population: the Baltimore Pediatric Eye Disease Study. Ophthalmology. 2009; 116:739–46.
4. Atkinson J, Braddick O, Robier B. . Two infant vision screen-ing programmes: prediction and prevention of strabismus and am-blyopia from photo- and videorefractive screening. Eye (Lond). 1996; 10:189–98.
5. Greenberg AE, Mohney BG, Diehl NN, Burke JP. Incidence and types of childhood esotropia: a population-based study. Ophthalmology. 2007; 114:170–4.
6. Birch EE, Fawcett SL, Morale SE. . Risk factors for accom-modative esotropia among hypermetropic children. Invest Ophthalmol Vis Sci. 2005; 46:526–9.
7. Cotter SA, Varma R, Tarczy-Hornoch K. . Risk factors asso-ciated with childhood strabismus: the multi-ethnic pediatric eye disease and Baltimore pediatric eye disease studies. Ophthalmology. 2011; 118:2251–61.
8. Choi DK, Choi MY. Clinical manifestation of patients with accom-modative esotropia for 10 years. J Korean Ophthalmol Soc. 2011; 52:1331–6.
9. Jun JH, Lee YC, Lee SY. Clinical features of refractive accom-modative esotropia according to degree of hypermetropia. J Korean Ophthalmol Soc. 2008; 49:617–22.
10. Kang IS, Park SW, Park YG. Clinical features of refractive accom-modative esotropia: long-term study. J Korean Ophthalmol Soc. 2008; 49:487–92.
11. Lim SJ, Cho YA. Bilateral hypermetropic amblyopia-in children with hyperopia of +6 diopters or more-. J Korean Ophthalmol Soc. 1994; 35:715–20.
12. Huynh SC, Wang XY, Ip J. . Prevalence and associations of anisometropia and aniso-astigmatism in a population based sample of 6 year old children. Br J Ophthalmol. 2006; 90:597–601.
13. Tarczy-Hornoch K. The epidemiology of early childhood hyperopia. Optom Vis Sci. 2007; 84:115–23.
14. Schoenleber DB, Crouch ER Jr. Bilateral hypermetropic amblyopia. J Pediatr Ophthalmol Strabismus. 1987; 24:75–7.
15. Friedman Z, Neumann E, Abel-Peleg B. Outcome of treatment of marked ametropia without strabismus following screening and di-agnosis before the age of three. J Pediatr Ophthalmol Strabismus. 1985; 22:54–7.
16. Friedman Z, Neumann E, Hyams SW, Peleg B. Ophthalmic screen-ing of 38,000 children, age 1 to 2 1/2 years, in child welfare clinics. J Pediatr Ophthalmol Strabismus. 1980; 17:261–7.
17. Tarczy-Hornoch K, Varma R, Cotter SA. . Risk factors for de-creased visual acuity in preschool children: the multi-ethnic pedia-tric eye disease and Baltimore pediatric eye disease studies. Ophthalmology. 2011; 118:2262–73.
18. Klimek DL, Cruz OA, Scott WE, Davitt BV. Isoametropic am-blyopia due to high hyperopia in children. J AAPOS. 2004; 8:310–3.
19. Chen W, Chen J, Zhang F. . Visual outcome in isoametropic amblyopic children with high hyperopia and the effect of therapy on retinal thickness. Am J Ophthalmol. 2013; 155:536–43.e1.
20. Weakley DR Jr, Birch E. The role of anisometropia in the develop-ment of accommodative esotropia. Trans Am Ophthalmol Soc. 2000; 98:71–6. discussion 76-9.
21. Coats DK, Avilla CW, Paysse EA. . Early-onset refractive ac-commodative esotropia. J AAPOS. 1998; 2:275–8.
22. Berk AT, Koçak N, Ellidokuz H. Treatment outcomes in refractive accommodative esotropia. J AAPOS. 2004; 8:384–8.
23. Birch EE. Marshall Parks lecture. Binocular sensory outcomes in accommodative ET. J AAPOS. 2003; 7:369–73.
Table 1.
Hyperopia | p-value∗ | |||
---|---|---|---|---|
≥1 D to <3 D (n = 156) | ≥3 D to <6 D (n = 169) | ≥6 D (n = 52) | ||
Age at first visit (years) | 3.96 ± 2.15 | 4.03 ± 2.17 | 3.73 ± 2.21 | 0.866 |
Final BCVA | 0.87 ± 0.16 | 0.83 ± 0.20 | 0.84 ± 0.20 | 0.294 |
Initial SE (D) | 1.95 ± 0.50 | 4.16 ± 0.78 | 7.30 ± 0.99 | <0.001 |
Final SE (D) | 0.84 ± 1.14 | 2.82 ± 1.48 | 5.45 ± 1.97 | <0.001 |
Anisometropia > 1 D (n, %) | 39/156 (25.0) | 45/169 (26.63) | 6/52 (11.54) | 0.069 |
Anisometropia > 2 D (n, %) | 25/156 (16.03) | 25/169 (14.79) | 1/52 (1.92) | 0.001 |
Unilateral amblyopia (n, %) | 45/156 (28.85) | 47/169 (27.81) | 6/52 (11.54) | 0.019 |
Bilateral ambylopia (n, %) | 8/156 (5.13) | 14/169 (8.28) | 20/52 (38.46) | <0.001 |
Acc esotropia (n, %) | 33/156 (21.15) | 78/169 (46.15) | 9/52 (17.31) | 0.015 |
Surgery of ET (n, %) | 35/69 (50.72) | 20/89 (22.47) | 2/21 (9.52) | 0.001 |
Table 2.
Hyperopia | ||||
---|---|---|---|---|
≥1 D to <3 D (n = 14) | ≥3 D to <6 D (n = 13) | ≥6 D (n = 8) | p-value† | |
Spherical equivalent (D) | ||||
Initial | 2.28 ± 0.39 | 4.00 ± 0.72 | 6.56 ± 1.12 | <0.001 |
Final‡ | 1.24 ± 0.91 | 2.42 ± 1.07 | 4.63 ± 1.71 | <0.001 |
Anisometropia (D) | ||||
Initial | 0.43 ± 0.65 | 0.50 ± 0.76 | 0.15 ± 0.38 | 0.145 |
Final‡ | 0.73 ± 0.79 | 0.75 ± 0.89 | 0.58 ± 0.52 | 0.546 |
Unilateral amblyopia (n, %) | ||||
Initial | 1/14 (7.14) | 1/13 (7.69) | 0/8 (0.0) | 0.533 |
Final‡ | 2/14 (14.29) | 2/13 (15.38) | 2/8 (25.0) | 0.502 |
Bilateral amblyopia (n, %) | ||||
Initial | 1/14 (7.14) | 1/13 (7.69) | 3/8 (37.5) | 0.387 |
Final‡ | 0/14 (0.0) | 0/13 (0.0) | 2/8 (25.0) | 0.144 |
Accommodative ET (n, %) | ||||
Initial | 3/14 (21.43) | 8/13 (61.54) | 4/8 (50.0) | 0.212 |
Final‡ | 2/14 (14.29) | 8/13 (61.54) | 4/8 (50.0) | 0.065 |
Hyperopic reduction rate (D/year) | 0.25 ± 0.19 | 0.30 ± 0.18 | 0.39 ± 0.36 | 0.435 |
Table 3.
Risk of anisometropia (≥1 D) | Risk of anisometropia (≥2 D) | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value∗ | OR | 95% CI | p-value∗ | |
Hyperopia | ||||||
≥1 D to <3 D | 1.769 | 0.785-3.987 | 0.114 | 1.232 | 1.137-1.335 | <0.001 |
≥3 D to <6 D | 1.855 | 0.829-4.154 | 0.089 | 1.217 | 1.128-1.312 | <0.001 |
≥6 D | 0.741 | 0.240-2.286 | 0.407 | 1.024 | 0.978-1.072 | 0.467 |
Table 4.
Risk of unilateral amblyopia | Risk of bilateral amblyopia | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value∗ | OR | 95% CI | p-value∗ | |
Hyperopia | ||||||
≥1 D to <3 D | 2.854 | 1.239-6.572 | 0.008 | 1.480 | 0.303-7.224 | 0.474 |
≥3 D to <6 D | 2.992 | 1.186-7.548 | 0.011 | 2.511 | 0.550-11.467 | 0.179 |
≥6 D | 1.356 | 0.418-4.393 | 0.416 | 14.796 | 3.173-68.999 | <0.001 |
Table 5.
Risk factors | Risk of esotropia | ||
---|---|---|---|
OR | 95% CI | p-value | |
Hyperopia | |||
≥1 D to <3 D | 1.263 | 0.657-2.431 | 0.483∗ |
≥3 D to <6 D | 1.862 | 1.169-3.579 | 0.044∗ |
≥6 D | 1.067 | 0.469-2.428 | 0.877∗ |
Anisometropia | |||
≥1 D | 1.090 | 0.609-1.964 | 0.699∗ |
≥2 D | 5.386 | 2.046-14.179 | 0.001† |
≥2 D with hyperopia (<3 D) | 8.039 | 2.637-24.508 | <0.001∗ |
≥2 D with hyperopia (≥3 D) | 3.231 | 1.276-8.182 | 0.009∗ |
Age at initial visit | |||
<2 years | 5.578 | 3.208-9.669 | <0.001† |
Table 6.
Non-surgery group (n = 132) | Surgery group (n = 69) | p-value∗ | |
---|---|---|---|
Age at first visit (years) | 3.49 ± 2.01 | 3.04 ± 2.69 | 0.191 |
Spherical equivalent (D) | 3.75 ± 1.87 | 2.39 ± 1.63 | <0.001 |
Anisometropia (D) | 0.58 ± 0.66 | 0.59 ± 0.87 | 0.912 |
Anisometropia >1 D (n, %) | 26/129 (20.16) | 13/69 (18.84) | 0.997 |
Unilateral amblyopia (n, %) | 35/132 (26.52) | 17/69 (24.64) | 0.473 |
Bilateral ambylopia (n, %) | 3/132 (2.27) | 0/69 (0.0) | 0.083 |
Glasses wearing (n, %) | 114/129 (88.37) | 50/69 (72.46) | 0.014 |
Angle of deviation (PD) | |||
Without correction | 22.00 ± 12.44 | 31.15 ± 14.04 | 0.001 |
With correction | 2.98 ± 5.10 | 24.77 ± 14.70 | <0.001 |
Table 7.
Acc (n = 102) | Partial Acc (n = 18) | Non-Acc (n = 48) | Infantile (n = 31) | p-value∗ | |
---|---|---|---|---|---|
Age at first visit (years) | 3.81 ± 2.29 | 3.78 ± 1.87 | 3.44 ± 2.24 | 1.32 ± 1.17 | <0.001 |
Final BCVA | 0.84 ± 0.19 | 0.88 ± 0.17 | 0.83 ± 0.20 | 0.83 ± 0.13 | 0.833 |
Initial SE (D) | 4.09 ± 1.79 | 3.19 ± 1.57 | 2.26 ± 1.66 | 2.27 ± 1.54 | <0.001 |
Final SE (D) | 3.09 ± 1.90 | 2.04 ± 1.71 | 0.64 ± 1.31 | 1.27 ± 1.55 | <0.001 |
Anisometropia (D) | 0.59 ± 0.69 | 0.51 ± 0.66 | 0.72 ± 0.97 | 0.41 ± 0.41 | 0.321 |
Unilateral amblyopia (n, %) | 36/102 (35.29) | 8/18 (44.44) | 5/48 (10.42) | 6/31 (19.35) | 0.003 |
Bilateral ambylopia (n, %) | 3/102 (2.94) | 0/18 | 0/48 | 0/31 | 0.413 |
Associated strabismus (n, %) | 10/102 (9.80) | 3/18 (16.67) | 13/48 (27.08) | 7/31 (22.58) | 0.036 |
Angle of deviation | |||||
Without correction | 21.70 ± 8.90 | 34.50 ± 13.03 | 26.80 ± 18.63 | 31.36 ± 9.24 | 0.013 |
With correction | 1.63 ± 3.19 | 19.50 ± 9.97 | 24.00 ± 17.22 | 25.00 ± 0.00 | <0.001 |
Surgery of ET (n, %) | 10†/102 (9.80) | 11/18 (61.11) | 23/48 (47.92) | 25/31 (80.65) | <0.001 |
Success rate of surgery (n, %) | 10/10 (100) | 8/11 (72.73) | 16/23 (69.57) | 12/25 (48.0) | 0.015 |